J. Marc Simard
16Patents
5h-index
3Co-inventors
59Inventor score
Filing activity: Aug 25, 1994 → Dec 21, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7285574B2 | Methods for treating neural cell swelling | Physics | 19 | Expired |
| US7872048B2 | Methods for treating spinal cord injury with a compound that inhibits a NCCa-ATP channel | Human Necessities | 17 | Active |
| US5436590A | Digital FSK demodulator with automatic offset cancellation | Electricity | 12 | Expired |
| US8980952B2 | Methods for treating brain swelling with a compound that blocks a non-selective cation channel | Physics | 10 | Active |
| US8318810B2 | Methods for treating neural cell swelling | Physics | 9 | Active |
| US8557867B2 | Inhibitors of NCCa-ATP channels for therapy | Human Necessities | 5 | Active |
| US9107932B2 | Methods for treating neural cell swelling | Physics | 3 | Active |
| US9511075B2 | Targeting NCCA-ATP channel for organ protection following ischemic episode | Human Necessities | 3 | Active |
| US10898496B2 | Targeting NCCa-ATP channel for organ protection following ischemic episode | Human Necessities | 3 | Active |
| US10533988B2 | Methods for treating central or peripheral nervous system damage | Physics | 0 | Active |
| US8569377B2 | Methods for treating spinal cord injury with a compound that inhibits a NCCA-ATP channel | Human Necessities | 0 | Active |
| US10166244B2 | Targeting NCCA-ATP channel for organ protection following ischemic episode | Human Necessities | 0 | Active |
| US9375438B2 | Inhibitors of NCCa-ATP channels for therapy | Human Necessities | 0 | Active |
| US10900040B2 | Methods of reducing or preventing intimal damage caused by mechanical stimulation of endothelial cells | Chemistry; Metallurgy | 0 | Active |
| US12121526B2 | Targeting NCCA-ATP channel for organ protection following ischemic episode | Human Necessities | 0 | Active |
| US10583094B2 | Therapeutic methods that target the NCCA-ATP channel | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.